1-4 of 4
Ashley Pandolfi
Close
Sort by
Journal Articles

PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome

Ashley Pandolfi, Robert F. Stanley, Yiting Yu, Boris Bartholdy, Gopichand Pendurti, Kira Gritsman, Jacqueline Boultwood, Jonathan Chernoff, Amit Verma, Ulrich Steidl
Journal: Blood
Blood (2015) 126 (9): 1118–1127.
https://doi.org/10.1182/blood-2014-12-618801
Published: 2015
Includes: Supplemental data
Journal Articles

PAK1 Is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Robert Stanley, Ashley Pandolfi, M.Sc., Amit Verma, MD, Ulrich Steidl, MD PhD, Jonathan Chernoff, MD PhD, Yiting Yu, PhD, Jacqueline Boultwood
Journal: Blood
Blood (2014) 124 (21): 4614.
https://doi.org/10.1182/blood.V124.21.4614.4614
Published: 2014
Journal Articles

H2.0-Like Homeobox (HLX) Causes Pre-Leukemic Myeloid Expansion and Initiates AML In Cooperation With FLT3-ITD

Ashley Pandolfi, M.Sc., Boris Bartholdy, Ph.D., Britta Will, PhD, Robert Stanley, Tihomira I Todorova, B.A., Christine McMahon, MD, Ulrich Steidl, MD PhD
Journal: Blood
Blood (2013) 122 (21): 4201.
https://doi.org/10.1182/blood.V122.21.4201.4201
Published: 2013
Journal Articles

H2.0-Like Homeobox (HLX) Induces Unlimited Clonogenicity, Blocks Differentiation, and Cooperates with FLT3-ITD in the Induction of Acute Myeloid Leukemia

Ashley Pandolfi, M.Sc., Boris Bartholdy, Ph.D., Masahiro Kawahara, MD, Laura Barreyro, Britta Will, PhD, Robert Stanley, Roth Michael, MD, Ujunwa Cynthia Okoye-Okafor, M.Sc., Tihomira I Todorova, B.A., Maria E. Figueroa, MD, Ari Melnick, MD, Constantine S. Mitsiades, MD, PhD, Ulrich Steidl, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 651.
https://doi.org/10.1182/blood.V120.21.651.651
Published: 2012